Phase II trial of clofarabine and daunorubicin as induction therapy for acute myeloid leukemia patients greater than or equal to 60 years of age

Authors:

Abstract
No abstract available
Funding Information
  • National Cancer Institute (CA16056)
  • Genzyme
  • Leonard S. LuVullo Endowment for Leukemia Research
  • Nancy C. Cully Endowment for Leukemia Research
  • Dennis Szefel Jr. Endowment
  • Babcock Family Endowment
  • Heidi Leukemia Research Fund, Buffalo, NY

This publication has 14 references indexed in Scilit: